Sanofi-Aventis Administrative Office
Makati City, Philippines
Corporate office
21st, 22nd and 23rd Floors One World Place Corporate Office, 32nd St, Taguig, Metro Manila
About Sanofi-Aventis Administrative Office
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Sanofi
18
Clinical Trials at Sanofi-Aventis Administrative Office
During the past decade, Sanofi-Aventis Administrative Office conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)
2003-08-01
2011-12-01
Completed
12,537
A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation
2005-06-01
2008-03-01
Completed
4,628
Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes
2005-12-01
2009-04-01
Terminated
18,695
Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery
2006-05-01
2007-06-01
Completed
705
Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach
2006-06-01
2010-10-01
Completed
3,202
Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension
2007-07-01
2010-01-01
Completed
1,617
Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder Dysfunction
2007-10-01
2009-12-01
Completed
172
An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without Diabetes
2008-01-01
2009-02-01
Terminated
165
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Sanofi-Aventis Administrative Office"
#1 collaborator was "Population Health Research Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Sanofi-Aventis Administrative Office
According to Clinical.Site data, the most researched conditions in "Sanofi-Aventis Administrative Office" are
"Diabetes Mellitus, Type 2" (4 trials), "Atrial Fibrillation" (2 trials), "Fatty Liver" (2 trials), "Hypertension" (2 trials) and "Venous Thromboembolism" (2 trials). Many other conditions were trialed in "Sanofi-Aventis Administrative Office" in a lesser frequency.
Clinical Trials Intervention Types at Sanofi-Aventis Administrative Office
Most popular intervention types in "Sanofi-Aventis Administrative Office" are "Drug" (17 trials) and "Device" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Placebo (for Rimonabant)" (4 trials), "Rimonabant" (4 trials), "Lixisenatide (AVE0010)" (3 trials) and "Metformin" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Sanofi-Aventis Administrative Office
The vast majority of trials in "Sanofi-Aventis Administrative Office" are
18 trials for "All" genders.
Clinical Trials Status at Sanofi-Aventis Administrative Office
Currently, there are NaN active trials in "Sanofi-Aventis Administrative Office".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 14 completed trials in Sanofi-Aventis Administrative Office,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Sanofi-Aventis Administrative Office, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 0 trials that are defined as “Not Applicable".